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Background: Gorgonians of the genus Eunicella are known for possessing a wide range of pharmacological activities
such as antiproliferative and antibacterial effect. The aim of this study was to evaluate the anti-inflammatory and
gastroprotective effect of the organic extract and its semi-purified fractions from the white gorgonian Eunicella
singularis and the isolation and identification of pure compound(s) from the more effective fraction.
Methods: Anti-inflammatory activity was evaluated, using the carrageenan-induced rat paw edema test and in
comparison to the reference drug Acetylsalicylate of Lysine. The gastroprotective activity was determined using
HCl/EtOH induced gastric ulcers in rats. The purification of compound(s) from the more effective fraction was done by
two chromatographic methods (HPLC and MPLC). The structure elucidation was determined by extensive spectroscopic
analysis (1H and 13C NMR, COSY, HMBC, HMQC and NOESY) and by comparison with data reported in the literature.
Results: The evaluation of the anti-inflammatory activity of different fractions from Eunicella singularis showed in a
dependent dose manner an important anti-inflammatory activity of the ethanol fraction, the percentage of inhibition
of edema, 3 h after carrageenan injection was 66.12%, more effective than the reference drug (56.32%). In
addition, this ethanolic fraction showed an interesting gastroprotective effect compared to the reference drugs,
ranitidine and omeprazol. The percentage of inhibition of gastric ulcer induced by HCl/ethanol in rats was 70.27%.
The percentage of the reference drugs (ranitidine and omeprazol) were 65 and 87.53%, respectively. The purification
and structure elucidation of compound(s) from this ethanolic fraction were leading to the isolation of five sterols:
cholesterol (5α-cholest-5-en-3β-ol) (1); ergosterol (ergosta-5,22-dien-3β-ol) (2); stigmasterol (24-ethylcholesta-5,
22-dien-3b-ol) (3); 5α,8α-epidioxyergosta 6,22-dien-3β-ol (4) and 3β-hydroxy-5α,8α-epidioxyergosta-6-ene (5); and one
diterpenoid: palmonine D (6).
Conclusion: Based on data presented here, we concluded that diterpenoids and sterols detected in the ethanolic
fraction can be responsible for its pharmacological activity.
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Nature has developed an enormous diversity during
several billion years of evolution. The Mediterranean
Area represents one of the world’s major centers of
animal diversity; with around 20 gorgonian species, four
belong to the genus Eunicella: E. verrucosa, E. filiformis, E.
cavolini and E. singularis [1].
Although natural compounds have been replaced by
synthetic chemistry as the main source of new drugs,
marine invertebrates remain an unequalled source of
biochemical diversity. The studies on gorgonian have
great importance in the research of marine resources of
active compounds mainly by the pharmaceutical industry
or for other uses. In fact, the gorgonians (Anthozoa,
Gorgonacea) are known for possessing a wide range of
pharmacologic and health promoting properties includ-
ing antibacterial [2], antiviral [3], antiplasmodial [4],
antifouling [5], antiproliferative [6], cytotoxic [7] and in-
secticidal [8] effects. The gorgonian of the genus Euni-
cella has been demonstrated to contain a wide variety of
natural products as steroids and diterpenes [9,10].
These compounds posses anticancer, gastroprotective
and anti-inflammatory activities [11]. For many years,
our marine pharmacological group in Tunisia has been
involved in an accurate research program on gorgonian
constituents in order to define both their chemical
composition and their biological activities. On the
other hand, the use of non-steroidal anti-inflammatory
drugs (NSAID) for the treatment of inflammatory dis-
eases is associated with adverse effects as peptic ulcer
[12]. Therefore, the research of potent anti-
inflammatory drugs from natural sources and with fewer
side effects had become necessary. This study has yielded
the anti-inflammatory and gastroprotective effects of the
organic extract and its semi-purified fractions of the white
gorgonian Eunicella singularis (Esper, 1791). The structure
elucidation of the isolated compounds from the active
fraction was done by 1D and 2D NMR experiments and
by comparison with literature data.
Methods
General procedures
HPLC was performed using a Waters model 510 pump
equipped with Waters Rheodine injector and a differential
refractometer, model 401. Medium pressure liquid chro-
matography (MPLC) was performed on a Buchi apparatus
using a silica gel (230–400 mesh) column.
NMR spectra were obtained on Varian Inova 400 and
Varian Inova 500 NMR spectrometers (1H at 400 and
500 MHz, 13C at 100 and 125 MHz, respectively) equipped
with a Sun hardware, δ (ppm), J in hertz, and spectra
referred to CD3Cl3 (δH=7.27; δC= 70.0 ) as internal
standard. High-resolution ESIMS spectra were performedwith a Micromass QTOF Micro mass spectrometer. All
reagents were commercially obtained (Aldrich, Fluka)
at the highest commercial quality and used without fur-
ther purification except where noted. All reactions were
monitored by TLC on silica gel plates (Macherey–Nagel).
Carrageenan (BDH Chemicals Ltd Poole England), Acetyl-
salicylate of Lysine (ASL) were purchased from Sigma
Chemical (Berlin, Germany). Ranitidine was obtained
from Medis (Tunis, Tunisia), omeprazole was obtained
from AstraZeneca (Monts).Collection and extraction
E. singularis was collected from the Mediterranean Sea in
various areas of the coastal region of Tabarka (Tunisia), in
June 2010, at a depth between 20 and 30 m. Identification
of specimens was carried out in the National Institute of
Marine Sciences and Technologies (Salamboo, Tunisia)
where a voucher specimen of E. singularis was deposited
under the following reference 1132. After maceration of
600 g of the powdered material with methanol and dichlo-
romethane (1:1, v/v) for 48h three times, the organic ex-
tract (40 g) was purified, using C18 cartridges (Sep-pack,
Supelco), by gradient elution with different organic sol-
vents in the order of decreased polarity: ethanol, acetone
and methanol/CH2Cl2 (1:1) to give three semi-purified
fractions: ethanol (F-EtOH), acetone (F-Ac) and methanol/
CH2Cl2 (F-MeOH/CH2Cl2) fractions. Organic solvents
were removed from recuperated fractions using rotating
evaporator at 40°C.Purification, isolation and structure elucidation
F-EtOH (15 g) was fractionated according to the Kupchan
partitioning procedure [13] as follow: the ethanolic fraction
was dissolved in a mixture of MeOH/H2O containing 10%
H2O and partitioned against n-hexane to give 10.3 g of the
crude extract. The water content (% v/v) of the MeOH
extract was adjusted to 30% and partitioned against CHCl3
to give 3.9 g of the crude extract. The aqueous phase was
concentrated to remove MeOH and then extracted with
n-BuOH (268 mg of crude extract) (Figure 1). The
n-hexane extract (5 g) was fractioned by silica gel MPLC
using a solvent gradient system from CH2Cl2 to MeOH.
Fraction eluted with CH2Cl2: MeOH 99:1 (307 mg) was
purified by HPLC on a Nucleodur 100–5 C18 (5 μm;
10 mm i.d. × 250 mm) with 99% MeOH: H2O as eluent
(flow rate 3mL/min) to give 1.3 mg of 5α-cholest-5-en-
3β-ol (1) (tR=55 min) and 2.4 mg of 24-ethylcholesta-5,
22-dien-3β-ol (3) (tR=83min) (Figure 1).
Fraction eluted with CH2Cl2:MeOH 95:5 (288 mg) was
purified by HPLC on a Nucleodur 100–5 C18 (5 μ, 4.6 mm
i.d. × 250 mm) with 95% MeOH:H2O as eluent (flow
rate 1 mL/min) to give 0.1 mg of ergosta-5,22-dien-3β-ol
(2) (tR=74 min) (Figure 1).
Figure 1 Purification and separation process of the isolation of six compounds from the ethanolic fraction from E. singularis.
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silica gel MPLC using a solvent gradient system from
CH2Cl2 to CH2Cl2: MeOH 1:1.
Fraction eluted with CH2Cl2: MeOH 95:5 (187.5 mg)
was further purified by HPLC on a Nucleodur 100–5 C18
(5 μ, 4.6 mm i.d. × 250 mm) with 80% MeOH:H2O as
eluent (flow rate 1 mL/min) to give 0.3 mg of 5α,8α-epi-
dioxyergosta 6,22-dien-3β-ol (4) (tR=29 min), and 0.6 mg
of 3β-hydroxy-5α,8α-epidioxyergosta-6-ene (5) (tR=2 min)
and 3 mg of palmonine D (6) (tR=3 min) (Figure 1).
The purities of compounds were determined to be
greater than 95% by HPLC and NMR. Furthermore,
HPLC chromatograms and spectroscopic data of each
compound were reported (Additional file 1).
Pharmacological evaluation
Animals
Wistar rats of either sex, weighing 150–200 g were
obtained from Pasteur Institute (Tunis, Tunisia). Housingconditions and in vivo experiments were approved accord-
ing to the guidelines established by the European Union
on Animal Care (CCE Council 86/609).
Carrageenan-Induced Rat Paw Edema
The anti-inflammatory activity of the organic extract
and its semi-purified fractions on carrageenan-induced
paw edema was determined according to Winter et al.
[14]. The animals were divided into eleven groups of six
rats each. The control group received an intraperitoneal
(i.p.) dose of saline solution (NaCl 9g/L, 2.5 mL/kg), the
reference group received Acetylsalicylate of Lysine (ASL)
(300 mg/kg, i.p.), and the test groups received the
organic extract of E. singularis (50, 100 and 200 mg/kg,
i.p.) and its semi-purified fractions F-EtOH, F-Ac and
F-MeOH/CH2Cl2 (25 and 50 mg/kg, i.p.). After 30 min,
0.05mL of a 1% carrageenan suspension was injected into
the left hind paw. The paw volume up to the tibiotarsal
articulation was measured using a plethysmometer (model
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at 0 h (V0) (before carrageenan injection) and 1, 3 and
5 h later (VT) (after carrageenan injection). Paw swell-
ing was determined for each rat and the difference
between VT and V0 was taken as the edema value. The
percentages of inhibition were calculated according to
the following formula:
% inhibition ¼  VT−V0ð Þcontrol– VT−V 0ð Þtreated group
= VT−V0ð Þcontrol
  100
Gastric lesions induced by HCl/ethanol
The gastroprotective activity of the organic extract of
E. singularis and its semi-purified fractions F-EtOH,
F-Ac and F-MeOH/CH2Cl2 was studied in 150 mM
HCl/EtOH induced gastric ulcer [15]. Rats were divided
into fifteen groups, fasted for 24 h prior receiving an intra-
peritoneal doses of vehicle (NaCl 9g/L, 2.5 mL/kg) for the
control group, organic extract (50, 100 and 200 mg/kg,
i.p.) and its semi-purified fractions F-EtOH, F-Ac and
F-MeOH/CH2Cl2 (5, 10 and 25 mg/kg, i.p.) for the twelve
test groups. Two other groups received ranitidine (60 mg/
kg, i.p.) and omeprazole (30 mg/kg, i.p.) as reference
drugs. After 30 min, all groups were orally treated with
1mL of 150 mM HCl/EtOH solution for gastric ulcer
induction. Animals were killed 1 h after the administration
of ulcerogenic agent, their stomachs were excised and
opened along the great curvature, washed and stretched
on cork plates. The surface was examined for the presence
of lesions and the extent of the lesions was measured. The
summative length of the lesions along the stomach was
recorded (mm) as lesion index.
Statistical analysis
Data are presented as the mean±standard error (s.e.m).
Statistical analysis was performed using Student’s t-test.
The significance of difference was considered to include
values of P<0.05.
Results and discussion
The current study was carried out to determine the in
vivo anti-inflammatory and gastroprotective activities of
the organic extract of E. singularis and its semi-purified
fractions. The chemical composition of the more effect-
ive fraction was determined by both 1D and 2D NMR
experiments.
As shown in Figure 2, 1D and 2D NMR analysis of the
ethanolic fraction (F-EtOH) from the gorgonian E. singu-
laris resulted in the identification of six compounds.
Compound 1 was isolated as colorless powder. The mo-
lecular formula was determined to be C27H46O. Analysis
of 1H and 13C NMR data evidenced a Δ5 dihydroxy-
steroid structure with a saturated C8 cholestane sidechain. Comparison with literature data allowed assigning
the 5α-cholest-5-ene-3β-ol (cholesterol) structure [16].
Compound 2 has a molecular formula of C28H46O as
determined by HRESIMS. Compound 2 was identified as
ergosta-5,22-dien-3β-ol (ergosterol) [17] (Figure 2). This
compound was also isolated from the soft coral Tubas-
traea coccinea and T. tagusensis [17].
Compound 3 was isolated as colorless powder. The
molecular formula was determined to be C28H46O. Its
identity was determined by 1D and 2D NMR data as
24-ethylcholesta-5,22-dien-3b-ol (stigmasterol) earlier iso-
lated from the halophyte Salicornia herbacea [18] and
then reported also from the plant Aglaia eximia [19].
Compound 4 was isolated as white powder. The
molecular formula was determined to be C28H44O3
by HRESIMS data. NMR data disclosed the 5α,8α-
epidioxyergosta 6,22-dien-3β-ol structure. This compound
was also isolated from the fungus Sporothrix schenckii [20]
and the fungus Cryptoporus volvatus [21].
Compound 5 has a molecular formula of C28H46O3 as
determined by HRESIMS. 1H and 13C NMR indicated
that compound 5 is the Δ22 derivative of compound 4.
Therefore compound 5 was identified as 3β-hydroxy-
5α,8α-epidioxyergosta-6-ene [21].
Compound 6 was isolated as colorless oil. The molecu-
lar formula was determined to be C24H36O6 by HRESIMS.
The analysis of 1H NMR spectrum clearly revealed an
eunicellin diterpenoid structure. The 13C NMR spectrum
revealed 24 carbon signals. 1H- and 13CNMR assignments
were carried out with the aid of the detailed 2D analyses
(COSY, HMQC, NOESY, and HMBC) and the resulting
NMR evidence revealed 6 to be defined as palmonine
D [22]. Three sterols named 5α, 8α-epidioxysterols,
pregnanes and 9,11-secosterols were separated from E.
cavolini, another specie of the genus Eunicella [10,11].
The five sterols identified in our study were isolated
for the first time from E. singularis and were not yet
found with another specie from this genus.
Palmonine D is also purified from E. labiata, another
specie of the genus Eunicella [22]. Other researchers
reported the isolation of five diterpenoids from the gor-
gonian E. labiata, labiatamide A, labiatamide B, labiatin
A, labiatin B and labiatin C [23] but these compounds
were not yet separated from E. singularis. Massileunicellin
A, was obtained from E. cavolini [24] but also was not
identified from E.singularis.
The results reported in Figures 3 and 4 showed the
anti-inflammatory effects of organic extract and its
semi-purified fractions from E. singularis administered
intraperitoneally.
E. singularis organic extract presented a dose- related,
statistically significant anti-inflammatory activity on car-
rageenan induced paw edema which was comparable
with the reference drug, Acetylsalicylate of Lysine (ASL),
Figure 2 Chemical structures of six compounds isolated from the white gorgonian E. singularis. Five sterols (1-5): 5α-cholest-5-en-3β-ol
(1); ergosta-5,22-dien-3β-ol (2); 24- ethylcholesta-5,22-dien-3b-ol (3); 5α,8α-epidioxyergosta 6,22-dien-3β-ol (4) and 3β-hydroxy- 5α,8α-epidioxyergosta-
6-ene (5); and one diterpenoid: palmonine D (6).
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hibition of edema at dose levels of 50, 100 and 200 mg/
kg were 42.61%, 56.47% and 64.31% (at 3 h), respectively
(Table 1). The semi-purified fractions (F-Ac, F-EtOH,
F-MeOH/CH2Cl2) were assessed for anti-inflammatoryFigure 3 Effect of intraperitoneal administration of the organic extrac
Values are mean ± SEM.effect at 25 and 50 mg/kg. A dose-related anti-inflamma-
tory property was observed for the three fractions with
highly significant activity of F-EtOH at dose 50 mg/kg
with a percentage of inhibition of 66.12% at 3 h. While F-
Ac and F-MeOH/CH2Cl2 at a dose of 50 mg/kg reducedt from E. singularis on the carrageenan-induced rat paw edema.
Figure 4 Effect of intraperitoneal administration of semi-purified fractions (F-Ac, F-EtOH and F-MeOH/CH2Cl2 from E. singularis on the
carrageenan-induced rat paw edema. Values are mean ± SEM.
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respectively. ASL as a reference standard drug inhibited
the edema formation due to carrageenan to an extent of
56.32% (at 3 h) at the dose of 300 mg/kg. The development
of edema induced by carrageenan corresponds to the
events in the acute phase of inflammation mediated by
histamine, bradykinin and prostaglandins produced under
an effect of cyclooxygenase-2 (COX-2) [25]. This enzyme
is an inducible cyclooxygenase which boosts the inflam-
matory response by COX-2 mediated prostaglandin E2
(PGE2) [26]. Hence, it is probably that the organic extract
and its semi-purified fractions from the gorgonian E.
singularis reduced inflammation by blocking the cyclooxy-
genase2 (COX-2). Morever, several studies reported
that steroids isolated from other species of the genusTable 1 Anti-inflammatory effect of the intraperitoneal admin
semi-purified fractions (F-EtOH, F-Ac and F-MeOH/CH2Cl2) and
carrageenan-induced rat paw edema test
Treatment Dose
(mg/kg)
Edema (10−2ml) (mean±s. e. m
1 h 3 h
Vehicle - 30.12±2.38 55.35±3.3
Organic extract 50 24.62±2.8 31.76±3.6*
100 22.22±2.9 23.94±4.1*
200 15.5±3.2* 19.75±2.4*
F-EtOH 25 19.73±1.6 42.74±2.7
50 12.25±1.5** 18.75±2**
F-Ac 25 21.55±2.6 48.24±2.4
50 20.63±2.4 27.55±3.2*
F-MeOH/CH2Cl2 25 22.85±3.2 39.67±2.6
50 20.82±2.4 25.02±2.9*
ASL 300 19.66±3.4 24.17±2.7*
Values are expressed as mean±SEM; n=6 animals. *P<0.01, **P<0.001.Eunicella have anti-inflammatory activity such as secos-
teroids [11]. The high anti-inflammatory activity of the
fraction F-EtOH can be related with the presence of its
main steroid constituents. The chemical analysis of this
fraction (F-EtOH) revealed the presence of five sterols:
5α-cholest-5-en-3β-ol (cholesterol) (1); ergosta-5,22-dien-
3β-ol (ergosterol) (2); 24-ethylcholesta-5,22-dien-3b-ol
(stigmasterol) (3); 5α,8α-epidioxyergosta 6,22-dien-3β-
ol (4) and 3β-hydroxy-5α,8α-epidioxyergosta-6-ene (5).
The gastroprotective effect of E. singularis organic
extract and its semi-purified fractions against HCl/EtOH
induced gastric damage in rats is shown in (Table 2) and
the results are comparable to that of the reference drugs
ranitidine, histamine H2 receptor antagonist, and omepra-
zole, a proton pump inhibitor [27]. Oral administration ofistration of E. singularis organic extract and its
of reference drug (Acetylsalicylate of Lysine; ASL) in
) Edema inhibition (%)
5 h 1 h 3 h 5 h
58.5±4.69 - - -
* 35.14±4.1* 18.26 42.61 39.92
* 27.95±1.5** 32.84 56.47 52.21
* 22.75±3.6** 48.53 64.31 61.11
51.26±2.6 34.49 22.78 12.36
20.37±2.4** 59.32 66.12 65.17
52.33±3.5 28.42 12.84 10.53
* 31.27±2.7* 31.48 50.22 46.54
44.2±4.8 24.12 28.32 24.43
* 34.79±3.4* 30.86 54.78 40.52
* 27.95±3.1** 34.71 56.32 52.22
Table 2 Effect of E. singularis organic extract and its
semi-purified fractions (F-EtOH, F-Ac, F-MeOH/CH2Cl2),
and of reference drugs (ranitidine and omeprazol) on
gastric ulcer induced by HCl/ethanol in rats
Treatment Dose (mg/kg) Ulcer index (mm) Inhibition (%)
Vehicle - 78.5±3,49 -
Organic extract 50 31.52±2,42** 59.84
100 24.46±2,48** 68.84
200 19.49±3,48** 75.16
F-EtOH 5 43.36±1,52* 44.76
10 37.20±3,05** 52.61
25 23.33±1** 70.27
F-Ac 25 61.97±0,7 21.05
F-MeOH/CH2Cl2 5 66.59±2,33 15.17
10 58.78±2,82 25.11
25 29.17±4,04** 62.84
Ranitidine 60 27.47±2.3** 65
Omeprazol 30 9.78±0,81* 87.53
Values are expressed as mean±SEM; n=6 animals. *P<0.01, **P<0.001.
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hemorrhage with lesion index of 78.5 mm in the untreated
group. Treatment of rats by organic extract of E. singularis
produced a significant decrease in gastric hemorrhage and
the lesion index was inhibited by 60, 68 and 75% at doses
of 50, 100 and 200 mg/kg, respectively. The semi-purified
fractions were assessed for gastroprotective activity at 5,
10 and 25 mg/kg. A dose-related gastroprotective effect
was observed for the fractions F-EtOH and F-MeOH/
CH2Cl2 with highly significant activity for the ethanolic
fraction (F-EtOH) at 25 mg/kg. The lesion index was
inhibited by 44, 52 and 70% at doses of 5, 10 and 25 mg/
kg, respectively; while in the ranitidine treated animals (60
mg/kg) the inhibition was 65%. F-Ac failed to protect
stomach tissues from mucosal damage. The two classical
ulcer drugs ranitidine and omeprazole showed a signifi-
cant activity with a percentage of inhibition of gastric
lesions of 65 and 87%, respectively. Some reports on the
gastroprotective effect of diterpenes belonging to different
structural skeletons are published [28]. In addition, an-
other studies demonstrated that several terpenes or their
derivatives posses gastroprotective activity in different
models of induced gastric lesions in animals [29]. This
gastroprotective effect seems to be related with an in-
crease of the defensive mechanisms of the stomach, such
as prostaglandin synthesis and mucus production [30].
Therefore, the involvement of diterpenoids palmonine D
6 isolated from the active fraction F-EtOH is hypothesized
and can be responsible for its high activity.
Furthermore, various phenolic compounds (alkaloids,
glycosides, and saponins) detected in E. singularis organic
extract and fractions [6] may be responsible for its activity.Several studies reported that alkaloids have anti-inflam-
matory and gastroprotective effects [31]. Also, Glycosides,
terpenoids and steroids detected in our samples are known
to have anti-inflammatory and gastroprotective properties
[10,32] The synergic effect of different compounds of E.
singularis ethanolic fraction may be responsible for its
higher anti-inflammatory and gastroprotective activities.
Furthermore, the high free radical scavenging activity of
F-EtOH in the DPPH test [6] suggests that the antioxidant
activity may be one of the mechanisms of its gastropro-
tective and anti-inflammatory properties, because both
ulcerous and inflammatory processes are related to an
increase of free radicals [33].Conclusion
In conclusion, the obtained results demonstrated that the
ethanolic fraction of E. singularis had the highest activity
in the two tests (anti-inflammatory and gastroprotective).
The structure elucidation of compounds isolated from
this fraction revealed the presence of five sterols and a
eunicellan-based diterpenoid which may be responsible
for its activity.Additional file
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